M3TRIQ provides an AI-powered platform for the de novo design of novel ligands, accelerating R&D cycles in biomaterials, therapeutics, and industrial biomanufacturing. The platform automates ligand discovery and simulates biological function and regulatory compliance, aiming to reduce media costs by up to 80% and streamline the path to commercialization.
Funding
Funding not disclosed
Founders
Product
Problem
Developing high-performance ligands for specific protein signaling pathways is a costly and time-consuming process, often involving extensive wet-lab experimentation. This leads to prolonged R&D cycles and significant expenditure on culture media, hindering the efficient scale-up of biomaterials, therapeutics, and industrial biomanufacturing processes.
Solution
M3TRIQ offers an AI-powered platform that automates the de novo design of novel ligands, precisely targeting desired protein signaling pathways. The system leverages in-silico prototyping and regulatory-aware design principles to significantly reduce culture media costs, projecting up to an 80% reduction. By simulating biological function, stability, and scalability early in the R&D pipeline, M3TRIQ accelerates decision-making and streamlines the path to commercialization. The platform's integrated regulatory intelligence also aids in identifying compliant ingredients and simulating bioreactor conditions, facilitating smoother tech transfer and faster regulatory approval.
Target Audience
The primary customers are R&D departments within the biomaterials, therapeutics, and industrial biomanufacturing sectors seeking to optimize ligand development and reduce associated operational costs.
Features
- De Novo Ligand Discovery Engine: Utilizes advanced neural network models to design novel small molecules optimized for receptor binding and species compatibility.
- Functional Assay Simulation Layer: Employs AI models trained on experimental data to predict cell growth and differentiation outcomes, minimizing wet-lab iterations.
- Media Cost-Efficacy Optimizer: Implements reinforcement learning algorithms to balance ingredient costs, chemical stability, and biological performance for scalable media formulations.
- Regulatory-Aware Design Filter: Screens potential ligand components for compliance with regulatory standards such as FDA and GRAS, facilitating smoother commercialization pathways.
- Cross-Industry Scalability: Applicable across biomaterials, therapeutics, and industrial biomanufacturing sectors with minimal adaptation.